Roche fosters diversity, equity and inclusion, representing the communities we serve. When dealing with healthcare on a global scale, diversity is an essential ingredient to success. We believe that inclusion is key to understanding people’s varied healthcare needs. Together, we embrace individuality and share a passion for exceptional care. Join Roche, where every voice matters.

The Position

A healthier future. It’s what drives us to innovate. To continuously advance science and ensure everyone has access to the healthcare they need today and for generations to come. Creating a world where we all have more time with the people we love. That’s what makes us Roche.

In Roche’s Pharmaceutical Research and Early Development organization (pRED) , we make transformative medicines for patients to tackle some of the world’s toughest unmet healthcare needs. At pRED, we are united by our mission to transform science into medicine. Together, we create a culture defined by curiosity, responsibility and humility, where our talented people are empowered and inspired to bring forward extraordinary life-changing innovation at speed.

This position is located in Investigative and Immunosafety, a department within the Pharmaceutical Sciences function. We drive the non-clinical safety assessment of drug candidates from small molecules to complex biological products during the discovery and development phases at Roche.

The Opportunity

We are offering an outstanding opportunity for a Predictive Safety Expert with expertise in renal toxicology to design and execute preclinical in vitro models to support prioritization and de-risking of novel therapeutic agents throughout the drug discovery and development process. This position will work closely with stakeholders from several disciplines including toxicology project leaders, small molecule research and DMPK.

• You propose, conduct and report investigative toxicology strategies to understand the mechanisms of renal toxicity.

• You support the development and automation of predictive safety models

• You are accountable for the scientific delivery of modern regulated and/or non-regulated toxicology assays to inform risk assessment of discovery and development projects.

• In this role, you will also drive the design and development of advanced methods in predictive toxicology (e.g. for novel modalities) and the application of these to inform decision-making.

• You collaborate with in vivo study teams through your expert knowledge of renal toxicology

Who you are

• You hold a PhD in Toxicology, Biology or a related discipline. A DABT or ERT certification is an asset.

• You bring a minimum of 10 years of experience in the biotech/pharmaceutical industry

• You have a proven track record in designing and implementing renal toxicology strategies & in vitro assays

• Previous toxicology leadership and experience in interacting with regulatorsis highly welcome; additionally, experience in assay automation is of benefit.

• You demonstrate excellent communication and collaboration skills

Who we are

At Roche, more than 100,000 people across 100 countries are pushing back the frontiers of healthcare. Working together, we’ve become one of the world’s leading research-focused healthcare groups. Our success is built on innovation, curiosity and diversity.

Basel is the headquarters of the Roche Group and one of its most important centres of pharmaceutical research. Over 10,700 employees from over 100 countries come together at our Basel/Kaiseraugst site, which is one of Roche`s largest sites. Read more .

Besides extensive development and training opportunities, we offer flexible working options, 18 weeks of maternity leave and 10 weeks of gender independent partnership leave. Our employees also benefit from multiple services on site such as child-care facilities, medical services, restaurants and cafeterias, as well as various employee events.

We believe in the power of diversity and inclusion, and strive to identify and create opportunities that enable all people to bring their unique selves to Roche.